In the BioHarmony Drug Report Database

"Preview" Icon

Guanfacine

Intuniv, Tenex (guanfacine) is a small molecule pharmaceutical. Guanfacine was first approved as Intuniv on 1986-10-27. It is used to treat attention deficit disorder with hyperactivity and hypertension in the USA. It has been approved in Europe to treat attention deficit disorder with hyperactivity. It is known to target alpha-2B adrenergic receptor, alpha-2C adrenergic receptor, and alpha-2A adrenergic receptor. Guanfacine’s patent is valid until 2022-07-04 (FDA).

 

Trade Name

 

Intuniv
 

Common Name

 

guanfacine
 

ChEMBL ID

 

CHEMBL862
 

Indication

 

attention deficit disorder with hyperactivity, hypertension
 

Drug Class

 

Antihypertensives (guanidine derivatives)

Image (chem structure or protein)

Guanfacine structure rendering